These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12904350)

  • 41. Optimisation of AP-PCR fingerprinting discriminatory power for clinical isolates of Pseudomonas aeruginosa.
    Dabrowski W; Czekajlo-Kolodziej U; Medrala D; Giedrys-Kalemba S
    FEMS Microbiol Lett; 2003 Jan; 218(1):51-7. PubMed ID: 12583897
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative typing of Pseudomonas aeruginosa by random amplification of polymorphic DNA or pulsed-field gel electrophoresis of DNA macrorestriction fragments.
    Renders N; Römling U; Verbrugh H; van Belkum A
    J Clin Microbiol; 1996 Dec; 34(12):3190-5. PubMed ID: 8940470
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid single-nucleotide polymorphism-based identification of clonal Pseudomonas aeruginosa isolates from patients with cystic fibrosis by the use of real-time PCR and high-resolution melting curve analysis.
    Anuj SN; Whiley DM; Kidd TJ; Ramsay KA; Bell SC; Syrmis MW; Grimwood K; Wainwright CE; Nissen MD; Sloots TP
    Clin Microbiol Infect; 2011 Sep; 17(9):1403-8. PubMed ID: 21129101
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful application of the DiversiLab repetitive-sequence-based PCR typing system for confirmation of the circulation of a multiresistant Pseudomonas aeruginosa clone in different hospital wards.
    Ratkai C; Peixe LV; Grosso F; Freitas AR; Antunes P; Fodor E; Hajdú E; Nagy E
    Diagn Microbiol Infect Dis; 2010 Jun; 67(2):202-6. PubMed ID: 20338712
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of Pseudomonas aeruginosa on the basis of polymerase chain reaction-amplified ribosomal DNA spacer polymorphisms.
    Kur J; Burkiewicz A; Zablocka A; Gospodarek E
    Acta Microbiol Pol; 1995; 44(2):111-7. PubMed ID: 8906931
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathogenic potential and genetic diversity of environmental and clinical isolates of Pseudomonas aeruginosa.
    Martins VV; Pitondo-Silva A; Manço Lde M; Falcão JP; Freitas Sdos S; da Silveira WD; Stehling EG
    APMIS; 2014 Feb; 122(2):92-100. PubMed ID: 23879442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales.
    Scott FW; Pitt TL
    J Med Microbiol; 2004 Jul; 53(Pt 7):609-615. PubMed ID: 15184530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of Pseudomonas aeruginosa, Burkholderia cepacia complex, and Stenotrophomonas maltophilia in respiratory samples from cystic fibrosis patients using multiplex PCR.
    da Silva Filho LV; Tateno AF; Velloso Lde F; Levi JE; Fernandes S; Bento CN; Rodrigues JC; Ramos SR
    Pediatr Pulmonol; 2004 Jun; 37(6):537-47. PubMed ID: 15114555
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Flagellin gene and protein variation amongst clinical isolates of Pseudomonas aeruginosa.
    Winstanley C; Coulson MA; Wepner B; Morgan JA; Hart CA
    Microbiology (Reading); 1996 Aug; 142 ( Pt 8)():2145-51. PubMed ID: 8760928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PCR-based detection of a cystic fibrosis epidemic strain of Pseudomonas Aeruginosa.
    Panagea S; Winstanley C; Parsons YN; Walshaw MJ; Ledson MJ; Hart CA
    Mol Diagn; 2003; 7(3-4):195-200. PubMed ID: 15068391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum beta-lactamases in the United Kingdom.
    Woodford N; Zhang J; Kaufmann ME; Yarde S; Tomas Mdel M; Faris C; Vardhan MS; Dawson S; Cotterill SL; Livermore DM
    J Antimicrob Chemother; 2008 Dec; 62(6):1265-8. PubMed ID: 18819973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pseudomonas aeruginosa serotype O12 outbreak studied by arbitrary primer PCR.
    Elaichouni A; Verschraegen G; Claeys G; Devleeschouwer M; Godard C; Vaneechoutte M
    J Clin Microbiol; 1994 Mar; 32(3):666-71. PubMed ID: 8195376
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of Pseudomonas aeruginosa by a duplex real-time polymerase chain reaction assay targeting the ecfX and the gyrB genes.
    Anuj SN; Whiley DM; Kidd TJ; Bell SC; Wainwright CE; Nissen MD; Sloots TP
    Diagn Microbiol Infect Dis; 2009 Feb; 63(2):127-31. PubMed ID: 19026507
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The molecular mechanism of acute lung injury caused by Pseudomonas aeruginosa: from bacterial pathogenesis to host response.
    Sawa T
    J Intensive Care; 2014; 2(1):10. PubMed ID: 25520826
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of different genotyping methods for Pseudomonas aeruginosa in a setting of endemicity in an intensive care unit.
    Speijer H; Savelkoul PH; Bonten MJ; Stobberingh EE; Tjhie JH
    J Clin Microbiol; 1999 Nov; 37(11):3654-61. PubMed ID: 10523569
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens- and non-contact lens-related keratitis.
    Choy MH; Stapleton F; Willcox MDP; Zhu H
    J Med Microbiol; 2008 Dec; 57(Pt 12):1539-1546. PubMed ID: 19018027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Virulence genes fliC, toxA and phzS are common among Pseudomonas aeruginosa isolates from diabetic foot infections.
    Ertugrul BM; Oryasin E; Lipsky BA; Willke A; Bozdogan B
    Infect Dis (Lond); 2018 Apr; 50(4):273-279. PubMed ID: 29078729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Arbitrary primed PCR fingerprinting and serotyping of clinical Pseudomonas aeruginosa strains.
    Hernández J; Ferrus MA; Hernández M; Owen RJ
    FEMS Immunol Med Microbiol; 1997 Jan; 17(1):37-47. PubMed ID: 9012442
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular epidemiology of clinically high-risk Pseudomonas aeruginosa strains: Practical overview.
    Sawa T; Momiyama K; Mihara T; Kainuma A; Kinoshita M; Moriyama K
    Microbiol Immunol; 2020 May; 64(5):331-344. PubMed ID: 31965613
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of type III secretion protein exoenzymes and antimicrobial susceptibility patterns from bloodstream isolates of patients with Pseudomonas aeruginosa bacteremia.
    Garey KW; Vo QP; Larocco MT; Gentry LO; Tam VH
    J Chemother; 2008 Dec; 20(6):714-20. PubMed ID: 19129069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.